Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,209,164
+$829,389 QoQ
Shares Held
12,753
+16.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.43%
of 13F equity value
Holder Rank
#1,607
of 4,152 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mendel Money Management holds $9,330,781 across 7 Drug Manufacturers - General names. ABBV ranks #1 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
12,753 | $3,209,164 | |
| 2 | LLY |
ELI LILLY & Co
|
1,491 | $1,788,350 | |
| 3 | AMGN |
Amgen Inc
|
3,315 | $1,200,427 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,050 | $1,034,425 | |
| 5 | JNJ |
Johnson & Johnson
|
3,869 | $982,609 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,125 | $773,832 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,935 | $341,974 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,209,164 | 12,753 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,379,775 | 10,942 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,549,719 | 11,159 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,634,693 | 11,379 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,210,362 | 11,908 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,461,231 | 11,747 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,181,267 | 12,275 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,273,982 | 11,515 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,241,251 | 13,067 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,418,834 | 13,283 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $2,119,834 | 13,679 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,373,140 | 9,212 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,177,809 | 8,742 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,257,110 | 7,888 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,428,836 | 15,029 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,970,068 | 14,679 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,143,321 | 13,994 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,374,749 | 14,649 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,392,589 | 10,285 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,153,669 | 10,695 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,209,753 | 10,740 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,221,803 | 11,290 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,220,438 | 11,390 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $969,621 | 11,070 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,075,071 | 10,950 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||